Effect of adiponectin on cardiac allograft vasculopathy.
暂无分享,去创建一个
M. Isobe | Y. Nakano | T. Ishihara | G. Haraguchi | M. Konishi | H. Ohigashi | K. Saito | Kiyomi Saito
[1] Philippe Froguel,et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects , 2003, Nature.
[2] O. Froy,et al. High-fat diet delays and fasting advances the circadian expression of adiponectin signaling components in mouse liver. , 2009, Endocrinology.
[3] J. Engel,et al. Structure-Function Studies of the Adipocyte-secreted Hormone Acrp30/Adiponectin , 2003, The Journal of Biological Chemistry.
[4] M. Isobe,et al. Blockade of the Interaction Between PD-1 and PD-L1 Accelerates Graft Arterial Disease in Cardiac Allografts , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[5] Y. Nakano,et al. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. , 1996, Journal of biochemistry.
[6] T. Funahashi,et al. Associations of Adiponectin Levels With Incident Impaired Glucose Metabolism and Type 2 Diabetes in Older Men and Women , 2006, Diabetes Care.
[7] T. Kadowaki,et al. Adiponectin and adiponectin receptors. , 2005, Endocrine reviews.
[8] T. Murohara,et al. Adiponectin and cardiovascular disease. , 2009, Circulation journal : official journal of the Japanese Circulation Society.
[9] T Nakamura,et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[10] Richard N. Mitchell,et al. Interleukin-10 (IL-10) augments allograft arterial disease: paradoxical effects of IL-10 in vivo. , 1999, The American journal of pathology.
[11] T. Funahashi,et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). , 1996, Biochemical and biophysical research communications.
[12] M. Isobe,et al. Pioglitazone Prevents Acute and Chronic Cardiac Allograft Rejection , 2006, Circulation.
[13] Marshall I Hertz,et al. Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult lung and heart-lung transplantation report--2006. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[14] Y. Nakano,et al. Adiponectin plays an important role in efficient energy usage under energy shortage. , 2006, Biochimica et biophysica acta.
[15] Y. Terauchi,et al. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. , 2001, The Journal of biological chemistry.
[16] T Nakamura,et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.
[17] Philipp E. Scherer,et al. A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes (*) , 1995, The Journal of Biological Chemistry.
[18] P. Froguel,et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions , 2007, Nature Medicine.
[19] W. von Scheidt,et al. Cardiac allograft vasculopathy: a review. , 1997, Circulation.
[20] Y. Nakano,et al. Adiponectin does not bind to gelatin: a new and easy way to purify high-molecular-weight adiponectin from human plasma , 2010, Journal of Lipid Research.
[21] M. Isobe,et al. Induction of immunologic tolerance to cardiac allograft by simultaneous blockade of inducible co-stimulator and cytotoxic T-lymphocyte antigen 4 pathway1 , 2003, Transplantation.
[22] Thomas Christen,et al. Adiponectin Inhibits Allograft Rejection in Murine Cardiac Transplantation , 2009, Transplantation.
[23] H. Scharnagl,et al. Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin. , 2005, The Journal of clinical endocrinology and metabolism.
[24] Jun Li,et al. Adenosine monophosphate activated protein kinase inhibition is protective in both sexes after experimental stroke , 2010, Neuroscience Letters.
[25] B. Spiegelman,et al. AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity (*) , 1996, The Journal of Biological Chemistry.
[26] Y. Terauchi,et al. The Mechanisms by Which Both Heterozygous Peroxisome Proliferator-activated Receptor γ (PPARγ) Deficiency and PPARγ Agonist Improve Insulin Resistance* , 2001, The Journal of Biological Chemistry.
[27] Li-Ling Wu,et al. Globular adiponectin inhibits angiotensin II‐induced nuclear factor κB activation through AMP‐activated protein kinase in cardiac hypertrophy , 2010, Journal of cellular physiology.
[28] T. Murohara,et al. Role of adiponectin in cardiovascular protection. , 2010, Circulation journal : official journal of the Japanese Circulation Society.
[29] K. Inukai,et al. Involvement of low adiponectin levels in impaired glucose tolerance. , 2008, Metabolism: clinical and experimental.
[30] HisanoriKosuge,et al. Attenuation of Graft Arterial Disease by Manipulation of the LIGHT Pathway , 2004 .
[31] S. Kihara,et al. Disturbed secretion of mutant adiponectin associated with the metabolic syndrome. , 2003, Biochemical and biophysical research communications.